May 18, 2026

4:00 PM EDT

Join Viq Pervaaz, Senior Vice President at NYC EDC,
Scott Metzner, President of the Janus Property
Company, and others to discuss the importance of
science and innovation, its impact on the West
Harlem/Upper-Manhattan community and the
important initiatives being developed by NYC EDC.

May 20, 2026

12:30 PM EDT

This half day summit hosted at West End Labs will gather professionals from the life science industry as well as the financial sector to discuss hot topics at the intersection of research and development and finance. The afternoon event will feature panel discussions, fireside chats and vision talks focusing on topics such as investment strategies, funding opportunities, and financial trends in the life sciences. The Summit will be followed by a networking reception.

June 3, 2026

1:00 PM EDT

Central New York Biotech Accelerator | 841 E. Fayette St., Syracuse, NY
Join NewYorkBIO for an afternoon dedicated to elevating early-stage innovation in life sciences. Our Mini Pitch Dayshowcases a select group of emerging biotech and life science companies presenting to a panel of seasoned investors, advisors, and industry experts for real-time feedback and mentorship.
Whether you are an entrepreneur, investor, or ecosystem partner, this is your chance to learn what makes an effective pitch, gain insight into investor perspectives, and connect with New York’s dynamic biotech community.
Please note: This Registration is for attendees only. Presenting companies have been pre-selected.
The afternoon concludes with a networking reception where conversation and collaboration continue over drinks and light bites.

June 10, 2026

10:00 AM EDT

Are you ready for your next milestone? NewYorkBIO and Egnyte are co-hosting a webinar to map the journey from company founding through the clinical stage. We will explore what a scalable, compliant data foundation looks like at each milestone and highlight common pitfalls that slow growing biotechs down. The discussion will draw on real-world examples from companies incubated by Third Rock Ventures and other growth-stage biotechs, including Nimbus Therapeutics, Foghorn Therapeutics, and BridgeBio.